Gordon Brandt's Net Worth
$327 Thousand
Who is Gordon Brandt?
Gordon Brandt does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include NASTECH PHARMACEUTICAL CO INC, and PHASERX, INC..
SEC CIK
Gordon Brandt's CIK is 0001251781
Past Insider Trading and Trends
2006 was Gordon Brandt's most active year for acquiring shares with 10 total transactions. Gordon Brandt's most active month to acquire stocks was the month of November. 2006 was Gordon Brandt's most active year for disposing of shares, totalling 21 transactions. Gordon Brandt's most active month to dispose stocks was the month of December. 2007 saw Gordon Brandt paying a total of $531,389.34 for 99,699 shares, this is the most they've acquired in one year. In 2006 Gordon Brandt cashed out on 83,175 shares for a total of $1,064,005.95, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NASTECH PHARMACEUTICAL CO INC (ATRX) Snapshot price: $0.0164
PresidentGordon Brandt owns 15,000 units of Nastech Pharmaceutical Co. Common Stock which is worth $246.00, 12,500 units of Nastech Pharmaceutical Co. Inc. Common Stock which is worth $205.00 and 41,705 units of Nastech Pharmaceutical Company Inc Common Stock which is worth $683.96. From 2003 to 2008 Gordon Brandt acquired a total of 101,201 shares in NASTECH PHARMACEUTICAL CO INC at a cost of $551,848.80, Gordon also disposed a total of 59,496 shares of NASTECH PHARMACEUTICAL CO INC equalling to $877,244.85.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.97% | 1.2K |
$2.00 | $2,399.00 | 41.7K |
Apr 1
| |||
Form 4
| +74.85% | 17.34K |
$3.60 | -$2,379.60 | 40.5K |
Dec 17 - Dec 19
| |||
Form 4
|
—
|
0
|
$12.11 | -$11,159.00 | 23.16K |
Scheduled
|
Apr 20
| ||
Form 4
| +107.48% | 12K |
$11.26 | -$18,645.50 | 23.16K |
Scheduled
|
Feb 6 - Feb 7
| ||
Form 4
| -5.58% | -660.00 |
$13.31 | -$8,784.60 | 11.16K |
Jan 22
| |||
Form 4
|
—
|
0
|
$11.79 | -$29,019.00 | 11.82K |
Jan 4
| |||
Form 4
| -5.40% | -675.00 |
$15.67 | -$10,577.25 | 11.82K |
Dec 22
| |||
Form 4
|
—
|
0
|
$13.59 | -$25,962.50 | 12.5K |
Dec 5
| |||
Form 4
|
—
|
0
|
$13.72 | -$27,313.00 | 12.5K |
Nov 3
| |||
Form 4
|
—
|
0
|
$13.07 | -$20,759.00 | 12.5K |
Oct 4
| |||
Form 4
|
—
|
0
|
$13.05 | -$20,571.00 | 12.5K |
Sep 6
| |||
Form 4
|
—
|
0
|
$11.92 | -$19,313.70 | 12.5K |
Aug 3
| |||
Form 4
|
—
|
0
|
$12.16 | -$32,675.50 | 12.5K |
Jul 6
| |||
Form 4
|
—
|
0
|
$11.85 | -$29,595.50 | 12.5K |
Jun 5
| |||
Form 4
|
—
|
0
|
$11.73 | -$28,401.00 | 12.5K |
May 11
| |||
Form 4
| -11.88% | -1.69K |
$18.34 | -$30,902.90 | 12.5K |
Mar 27
| |||
Form 4
| -5.43% | -815.00 |
$14.40 | -$11,736.00 | 14.19K |
Jan 23
| |||
Form 4
| +100.00% | 7.5K |
—
|
—
| 15K |
Dec 16
| |||
Form 4
|
∞
| 7.5K |
—
|
—
| 7.5K |
Jan 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
| No matching records found | |||||||||
PHASERX, INC. No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||